RU2008118422A - Производные 5-хинолина, обладающие антибактериальной активностью - Google Patents
Производные 5-хинолина, обладающие антибактериальной активностью Download PDFInfo
- Publication number
- RU2008118422A RU2008118422A RU2008118422/04A RU2008118422A RU2008118422A RU 2008118422 A RU2008118422 A RU 2008118422A RU 2008118422/04 A RU2008118422/04 A RU 2008118422/04A RU 2008118422 A RU2008118422 A RU 2008118422A RU 2008118422 A RU2008118422 A RU 2008118422A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- alkenyl
- group
- heteroalkyl
- halogen
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims abstract 15
- 150000001875 compounds Chemical class 0.000 claims abstract 14
- 125000004404 heteroalkyl group Chemical group 0.000 claims abstract 12
- -1 hydroxy, amino Chemical group 0.000 claims abstract 12
- 229910052736 halogen Inorganic materials 0.000 claims abstract 11
- 150000002367 halogens Chemical group 0.000 claims abstract 11
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract 10
- 239000001257 hydrogen Substances 0.000 claims abstract 10
- 150000002431 hydrogen Chemical group 0.000 claims abstract 9
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract 7
- 125000004916 (C1-C6) alkylcarbonyl group Chemical group 0.000 claims abstract 6
- 125000003342 alkenyl group Chemical group 0.000 claims abstract 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract 6
- 125000000304 alkynyl group Chemical group 0.000 claims abstract 6
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims abstract 6
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims abstract 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract 5
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims abstract 4
- 125000003277 amino group Chemical group 0.000 claims abstract 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 4
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims abstract 4
- 150000003573 thiols Chemical group 0.000 claims abstract 4
- 125000003545 alkoxy group Chemical group 0.000 claims abstract 3
- 125000005119 alkyl cycloalkyl group Chemical group 0.000 claims abstract 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract 3
- 125000003118 aryl group Chemical group 0.000 claims abstract 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract 3
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims abstract 3
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims abstract 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims abstract 2
- 150000001540 azides Chemical class 0.000 claims abstract 2
- 125000000000 cycloalkoxy group Chemical group 0.000 claims abstract 2
- 125000005843 halogen group Chemical group 0.000 claims abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims abstract 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 125000004450 alkenylene group Chemical group 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 125000004419 alkynylene group Chemical group 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 125000004474 heteroalkylene group Chemical group 0.000 claims 1
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 1
- 125000006588 heterocycloalkylene group Chemical group 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- UUEVFMOUBSLVJW-UHFFFAOYSA-N oxo-[[1-[2-[2-[2-[4-(oxoazaniumylmethylidene)pyridin-1-yl]ethoxy]ethoxy]ethyl]pyridin-4-ylidene]methyl]azanium;dibromide Chemical compound [Br-].[Br-].C1=CC(=C[NH+]=O)C=CN1CCOCCOCCN1C=CC(=C[NH+]=O)C=C1 UUEVFMOUBSLVJW-UHFFFAOYSA-N 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- CYRMSUTZVYGINF-UHFFFAOYSA-N trichlorofluoromethane Chemical compound FC(Cl)(Cl)Cl CYRMSUTZVYGINF-UHFFFAOYSA-N 0.000 claims 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 6
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
1. Соединения формулы (I) ! ! где R1 означает водород, галоген, гидрокси, амино, циано, нитро, тиол, C1-С6алкил, С2-С6алкенил, С2-С6алкинил, гетероалкил, алкилокси, гетероалкилокси, циклоалкилокси, алкилциклоалкилокси, гетероциклоалкилокси или гетероалкилциклоалкилокси, ! R2 означает водород, галоген, гидрокси, амино, циано, C1-С6алкил, С2-С6алкенил, С2-С6алкинил или гетероалкил, ! R3 означает группу формулы ! ! где U и V независимо друг от друга означают атомы азота или группы формулы СН или CR6, ! R4 независимо друг от друга означают галоген, гидрокси, амино, циано, нитро или тиол, алкил, алкенил, алкинил или гетероалкил, ! n равно 0, 1 или 2, ! R5 означает алкил, алкенил, алкинил, гетероалкил, арил, гетероарил, циклоалкил, алкилциклоалкил, гетероалкилциклоалкил, гетероциклоалкил, аралкил или гетероаралкил, ! R6 независимо друг от друга означают атом галогена, гидрокси, алкил, алкенил, алкинил или гетероалкил, ! А выбирают из группы, включающей -CR10(OR11)CR12R13-, -CR8R9CR10(OR11)-, -OCR8R9CR12R13-, -CR8R9CR12R13O-, -CR8R9SO2-, -SO2CR8R9-, -CR8R9NR7-, -NR7CR8R9-, -CR8R9O-, -OCR8R9-, -CR8R9S-, -SCR8R9-, -NR7C(=O)-, -C(=O)NR7- и -CR8R9CR12R13-, ! R7 означает водород, трифторметил, C1-С6алкил, С2-С6алкенил, C1-С6влкоксикарбонил, C1-С6алкилкарбонил или карбониламино, где аминогруппа в составе карбониламиногруппы, при возможности, замещена группой C1-С6алкоксикарбонил, C1-С6алкилкарбонил, С2-С6алкенилоксикарбонил, С2-С6алкенилкарбонил, C1-С6алкил, С2-С6алкенил и, при возможности, дополнительно замещена группой C1-С6алкил или С2-С6алкенил, ! R8, R9, R10, R12 и R13 независимо друг от друга означают водород, галоген, азид, трифторметил, гидрокси, амино, C1-С6алкилокси, C1-С6алкилтио, C1-С6алкил, С2-С6алкенил, C1-С6алкоксикарбонил, С2-С6алкенилоксикарбонил, C1-С6алкилсульфонил, С2-С6�
Claims (13)
1. Соединения формулы (I)
где R1 означает водород, галоген, гидрокси, амино, циано, нитро, тиол, C1-С6алкил, С2-С6алкенил, С2-С6алкинил, гетероалкил, алкилокси, гетероалкилокси, циклоалкилокси, алкилциклоалкилокси, гетероциклоалкилокси или гетероалкилциклоалкилокси,
R2 означает водород, галоген, гидрокси, амино, циано, C1-С6алкил, С2-С6алкенил, С2-С6алкинил или гетероалкил,
R3 означает группу формулы
где U и V независимо друг от друга означают атомы азота или группы формулы СН или CR6,
R4 независимо друг от друга означают галоген, гидрокси, амино, циано, нитро или тиол, алкил, алкенил, алкинил или гетероалкил,
n равно 0, 1 или 2,
R5 означает алкил, алкенил, алкинил, гетероалкил, арил, гетероарил, циклоалкил, алкилциклоалкил, гетероалкилциклоалкил, гетероциклоалкил, аралкил или гетероаралкил,
R6 независимо друг от друга означают атом галогена, гидрокси, алкил, алкенил, алкинил или гетероалкил,
А выбирают из группы, включающей -CR10(OR11)CR12R13-, -CR8R9CR10(OR11)-, -OCR8R9CR12R13-, -CR8R9CR12R13O-, -CR8R9SO2-, -SO2CR8R9-, -CR8R9NR7-, -NR7CR8R9-, -CR8R9O-, -OCR8R9-, -CR8R9S-, -SCR8R9-, -NR7C(=O)-, -C(=O)NR7- и -CR8R9CR12R13-,
R7 означает водород, трифторметил, C1-С6алкил, С2-С6алкенил, C1-С6влкоксикарбонил, C1-С6алкилкарбонил или карбониламино, где аминогруппа в составе карбониламиногруппы, при возможности, замещена группой C1-С6алкоксикарбонил, C1-С6алкилкарбонил, С2-С6алкенилоксикарбонил, С2-С6алкенилкарбонил, C1-С6алкил, С2-С6алкенил и, при возможности, дополнительно замещена группой C1-С6алкил или С2-С6алкенил,
R8, R9, R10, R12 и R13 независимо друг от друга означают водород, галоген, азид, трифторметил, гидрокси, амино, C1-С6алкилокси, C1-С6алкилтио, C1-С6алкил, С2-С6алкенил, C1-С6алкоксикарбонил, С2-С6алкенилоксикарбонил, C1-С6алкилсульфонил, С2-С6алкенилсульфонил или сульфониламиногруппу, где аминогруппа в составе сульфониламиногруппы, при возможности, замещена группой C1-С6алкил или фенил,
R11 означает водород, трифторметил, C1-С6алкил, С2-С6алкенил, C1-С6алкоксикарбонил, C1-С6алкилкарбонил или карбониламиногруппу, где аминогруппа в составе карбониламиногруппы, при возможности, замещена группой C1-С6алкоксикарбонил, C1-С6алкилкарбонил, С2-С6алкенилоксикарбонил, С2-С6алкенилкарбонил, C1-С6алкил, С2-С6алкенил и, при возможности, дополнительно замещена группой C1-С6алкил или С2-С6алкенил,
или их фармацевтически приемлемая соль, сольват, гидрат или фармацевтически приемлемая лекарственная форма.
2. Соединения по п.1, где А выбирают из группы, включающей -СН(ОН)СН2-, -СН2СН(ОН)-, -ОСН2СН2-, -СН2СН2О-, -СН2SО2-, -SO2СН2-, -СН2N(С1-С4алкил)-, -N(С1-С4алкил)СН2-, -СН2NН-, -NНСН2-, -СН2О-, -ОСН2-, -СН2S-, -SCH2-, -N(С1-С4алкил)С(=O)-, -С(=O)N(С1-С4алкил)-, -NHC(=O)-, -C(=O)NH- или -СН2СН2-.
3. Соединения по п.1, где А означает группу формулы -CH(OH)CH2- или -OCH2CH2-.
4. Соединения по п.1, где R1 ознчает метокси.
5. Соединения по п.1, где R2 означает водород или галоген.
6. Соединения по п.1, где R5 означает группу формулы -B-Y, где В означает химическую связь, алкилен, алкенилен, алкинилен, -NH-, -NHSO2-, -SO2-, -С(=O)-, гетероалкилен или гетероциклоалкилен, a Y означает арил, гетероарил, аралкил, гетероаралкил, циклоалкил, гетероциклоалкил, алкилциклоалкил, гетероалкилциклоалкил, гетероарилгетероциклоалкил или арилгетероциклоалкил.
7. Соединения по п.6, где В означает группу формулы -NH-, -NHCH2-, -CH2NH-, -NHCH2CH2-, -CH2CH2NH-, -NHCH2CH2CH2-, -СН2СН2СН2NН-, -СН2-, -СН2СН2-, -СН2СН2СН2-, -NHC(=O)-, -C(=O)NH-, -СН(ОН)-, -СН2CH(ОН)-, -СН(ОН)СН2-, -NHSO2-, -SO2NH-, -SO2-, -C(=S)NH-, -NHC(=S)-, -C(=NOH)-, -CH2C(=NOH)-, -C(=NOH)CH2-, -C(=O)-, -C(=O)-C(=O)-, -CH2C(=O)-, -C(=O)CH2-, -N(С1-С4алкил)СН2-, -СН2N(С1-С4алкил)- или пиперазин.
10. Соединения по п.9, где R4 независимо друг от друга означают галоген, гидрокси, циано, С1-С4алкил или С1-С4гетероалкил.
11. Соединения по п.9, где R6 независимо друг от друга означают галоген, гидрокси, С1-С4алкил или С1-С4гетероалкил.
12. Фармацевтические композиции, содержащие в качестве активного ингредиента соединение по пп.1-11 и необязательно носители и/или адъюванты.
13. Применение соединения или фармацевтической композиции по пп.1-12 для лечения бактериальных инфекций.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005049039 | 2005-10-13 | ||
DE102005049039.5 | 2005-10-13 | ||
DE102006028649A DE102006028649A1 (de) | 2006-06-22 | 2006-06-22 | Neue Verbindungen mit antibakterieller Aktivität |
DE102006028649.9 | 2006-06-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2008118422A true RU2008118422A (ru) | 2009-11-20 |
Family
ID=37762231
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2008118422/04A RU2008118422A (ru) | 2005-10-13 | 2006-10-13 | Производные 5-хинолина, обладающие антибактериальной активностью |
Country Status (8)
Country | Link |
---|---|
US (1) | US20100324030A1 (ru) |
EP (1) | EP1943222A1 (ru) |
JP (1) | JP2009511530A (ru) |
KR (1) | KR20080064953A (ru) |
BR (1) | BRPI0617376A2 (ru) |
CA (1) | CA2625687A1 (ru) |
RU (1) | RU2008118422A (ru) |
WO (1) | WO2007042325A1 (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY150958A (en) * | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
US20100144717A1 (en) * | 2006-12-15 | 2010-06-10 | Janelle Comita-Prevoir | 2-quinolinone and 2-quinoxalinone-derivatives and their use as antibacterial agents |
EP2155716A2 (en) * | 2007-05-09 | 2010-02-24 | Pfizer Inc. | Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
US8012961B2 (en) | 2008-04-15 | 2011-09-06 | Actelion Pharmaceutical Ltd. | Tricyclic antibiotics |
WO2016056581A1 (ja) * | 2014-10-08 | 2016-04-14 | 国立研究開発法人理化学研究所 | 植物成長促進剤及び植物成長促進方法 |
MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
US10752588B2 (en) | 2014-12-19 | 2020-08-25 | The Broad Institute, Inc. | Dopamine D2 receptor ligands |
WO2016100940A1 (en) | 2014-12-19 | 2016-06-23 | The Broad Institute, Inc. | Dopamine d2 receptor ligands |
NZ763766A (en) | 2017-03-20 | 2023-07-28 | Novo Nordisk Healthcare Ag | Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators |
BR112021005188A2 (pt) | 2018-09-19 | 2021-06-08 | Forma Therapeutics, Inc. | tratamento de anemia falciforme com um composto de ativação de piruvato cinase r |
JP7450610B2 (ja) | 2018-09-19 | 2024-03-15 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | ピルビン酸キナーゼrの活性化 |
US20210379052A1 (en) * | 2018-09-27 | 2021-12-09 | Shenzhen Chipscreen Biosciences Co., Ltd. | Quinoline derivative having indoleamine-2,3-dioxygenase inhibitory activity |
WO2023078252A1 (en) | 2021-11-02 | 2023-05-11 | Flare Therapeutics Inc. | Pparg inverse agonists and uses thereof |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3600390A1 (de) * | 1986-01-09 | 1987-07-16 | Hoechst Ag | Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel |
CA1340821C (en) * | 1988-10-06 | 1999-11-16 | Nobuyuki Fukazawa | Heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components |
WO1998050364A1 (en) * | 1997-05-03 | 1998-11-12 | Smithkline Beecham Plc | Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors |
TWI250152B (en) * | 1998-07-21 | 2006-03-01 | Eisai Co Ltd | N,N-substituted cyclic amine compounds used as calcium antagonizer |
ATE316969T1 (de) * | 1998-10-08 | 2006-02-15 | Smithkline Beecham Plc | Tetrahydrobenzazepin-derivate verwendbar als dopamin-d3-rezeptor-modulatoren (antipsychotische mittel) |
AU2002224791A1 (en) * | 2000-10-26 | 2002-05-06 | Smithkline Beecham P.L.C. | Benzoxazinone derivatives, their preparation and use |
TW200409637A (en) * | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
DE10316081A1 (de) * | 2003-04-08 | 2004-10-21 | Morphochem AG Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
GB0319150D0 (en) * | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Novel compounds |
JP2007529511A (ja) * | 2004-03-17 | 2007-10-25 | グラクソ グループ リミテッド | M3ムスカリン性アセチルコリン受容体アンタゴニスト |
WO2005094834A1 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
TWI391387B (zh) * | 2004-05-12 | 2013-04-01 | Eisai R&D Man Co Ltd | 具有哌啶環之吲哚衍生物 |
DE102004041163A1 (de) * | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
WO2006038172A1 (en) * | 2004-10-05 | 2006-04-13 | Actelion Pharmaceuticals Ltd | New piperidine antibiotics |
WO2006099884A1 (en) * | 2005-03-24 | 2006-09-28 | Actelion Percurex Ag | Beta-aminoalcohol antibiotics |
AU2006268531A1 (en) * | 2005-07-11 | 2007-01-18 | Sanofi-Aventis | Novel 2,4-dianilinopyrimidine derivatives, the preparation thereof, their use as medicaments, pharmaceutical compositions and, in particular, as IKK inhibitors |
-
2006
- 2006-10-13 KR KR1020087009733A patent/KR20080064953A/ko not_active Application Discontinuation
- 2006-10-13 WO PCT/EP2006/009932 patent/WO2007042325A1/de active Application Filing
- 2006-10-13 BR BRPI0617376-4A patent/BRPI0617376A2/pt not_active IP Right Cessation
- 2006-10-13 CA CA002625687A patent/CA2625687A1/en not_active Abandoned
- 2006-10-13 EP EP06806274A patent/EP1943222A1/de not_active Withdrawn
- 2006-10-13 JP JP2008534946A patent/JP2009511530A/ja not_active Withdrawn
- 2006-10-13 RU RU2008118422/04A patent/RU2008118422A/ru not_active IP Right Cessation
-
2008
- 2008-04-11 US US12/082,667 patent/US20100324030A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1943222A1 (de) | 2008-07-16 |
JP2009511530A (ja) | 2009-03-19 |
BRPI0617376A2 (pt) | 2011-07-26 |
WO2007042325A1 (de) | 2007-04-19 |
KR20080064953A (ko) | 2008-07-10 |
CA2625687A1 (en) | 2007-04-19 |
US20100324030A1 (en) | 2010-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2008118422A (ru) | Производные 5-хинолина, обладающие антибактериальной активностью | |
RU2007105995A (ru) | Новые соединения, обладающие антибактериальной активностью | |
RU2327701C2 (ru) | Нуклеозидные производные и фармацевтическая композиция, обладающая антивирусной активностью в отношении hcv | |
HUP0402310A2 (hu) | 1,6-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények | |
RU2400483C2 (ru) | Пуриновые производные в качестве агонистов рецептора a2a | |
RU2342367C2 (ru) | Ненуклеозидные ингибиторы i обратной транскриптазы, предназначенные для лечения заболеваний, опосредованных вич | |
RU2009102252A (ru) | Хиноксалинилмакроциклические ингибиторы серинпротеазы вируса гепатита с | |
DK1389617T3 (da) | Heterocyclisk forbindelse og antitumormiddel indeholdende denne som den aktive bestanddel | |
CA2615022A1 (en) | Hcv ns3 protease inhibitors | |
EA200600225A1 (ru) | Производные пиперазина для лечения вич инфекций | |
RU2008107972A (ru) | Макроциклические пептиды в качестве ингибиторов ns3-протеазы hcv | |
AR041009A1 (es) | Compuestos heterociclicos nitrogenados que presentan actividad inhibitoria contra la integrasa del vih | |
RU2005134162A (ru) | Новые соединения с антибактериальным действием | |
AR037329A1 (es) | Compuestos pirazolo pirimidinona, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y usos de los mismos en la preparacion de medicamentos | |
CA2445190A1 (en) | Indole, azaindole and related heterocyclic amidopiperazine derivatives | |
KR950018010A (ko) | 단백질 키나제 c억제제 | |
RU2009139920A (ru) | Изоксазолиновые соединения и их применение в борьбе с вредителями | |
NO20052074L (no) | Substituerte benzoksazinoner og anvendelser derav. | |
MY140528A (en) | Spiroketal derivatives and their use as therapeutic agents for diabetes | |
RU2008125158A (ru) | Гетероциклические соединения, обладающие ингибирующей активностью по отношению к 11-гидроксистероиддегидрогеназе 1 типа | |
RU2008120601A (ru) | Производные аминодигидротиазина | |
TW200716528A (en) | Cyclopropanecarboxamide derivatives | |
AR036046A1 (es) | Inhibidores de la hiv proteasa, composiciones que las contienen y sus usos farmaceuticos | |
RU2009115963A (ru) | Производные оксадиазола, обладающие противовоспалительными и иммунодепрессантными свойствами | |
DK1412354T3 (da) | Derivater af triazolylimidazopyridin og af triazolylpurinerne, der er egnede som ligander for adenosin A2a?-receptoren og deres anvendelse som medikamenter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20111111 |
|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20091217 |